Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Javier Montero Hernández, Lidia Remolí Sargues, Clara Monferrer Adsuara, Verónica Castro Navarro, Catalina Navarro Palop & Enrique Cervera Taulet. (2023) Two-Year Results of a Treat and Extend Regimen with Aflibercept in Caucasian Patients with Pachychoroid Neovasculopathy. Seminars in Ophthalmology 38:4, pages 352-357.
Read now
Read now
Articles from other publishers (4)
Elon H. C. van Dijk, Helena M. A. Feenstra, Jakob Bjerager, Jakob Grauslund, Camiel J. F. Boon & Yousif Subhi. (2022)
Comparative efficacy of treatments for chronic central serous chorioretinopathy: A systematic review with network
meta‐analyses
. Acta Ophthalmologica 101:2, pages 140-159.
Crossref
Crossref
Su Yeon Han, Seung Hoon Lee, Phil-kyu Lee, Ho Ra & Jiwon Baek. (2023) Choroidal Morphology on Ultra-Widefield Indocyanine Green Angiography and Response to Aflibercept in Pachychoroid Neovasculopathy. Pharmaceuticals 16:1, pages 73.
Crossref
Crossref
Kenji Yamashiro, Yasuo Yanagi, Hideki Koizumi, Hidetaka Matsumoto, Chui Ming Gemmy Cheung, Fumi Gomi, Tomohiro Iida & Akitaka Tsujikawa. (2022) Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy. Journal of Clinical Medicine 11:15, pages 4614.
Crossref
Crossref
Benedikt Schworm, Nikolaus Luft, Leonie F. Keidel, Thomas C. Kreutzer, Tina R. Herold, Siegfried G. Priglinger & Jakob Siedlecki. (2021) Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy. BMC Ophthalmology 21:1.
Crossref
Crossref